STOCK TITAN

AtriCure director's trust proposes $143K share sale

AtriCure, Inc. (ATRC) common shares are listed for a proposed sale for the account of B Kristine Johnson Declaration Trust: 2,452 shares with an aggregate market value of $143,397.13.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

AtriCure, Inc. (ATRC) common shares are listed for a proposed sale for the account of B Kristine Johnson Declaration Trust: 2,452 shares with an aggregate market value of $143,397.13. The notice lists November 6, 2026 as the approximate sale date and Morgan Stanley Smith Barney LLC as broker. Beth Kristine Johnson signed as trustee; the notice identifies her as a director. The shares are described as acquired through restricted stock vesting under a registered plan on May 20, 2021.

Common shares proposed for sale 2,452 shares For the account of B Kristine Johnson Declaration Trust
Aggregate market value $143,397.13 Proposed sale
Shares outstanding 50,922,283 shares AtriCure shares outstanding listed in the notice
Approximate sale date November 6, 2026 Proposed sale
Acquisition date May 20, 2021 Shares acquired through restricted stock vesting under a registered plan
Rule 144 regulatory
"definition of "person" in paragraph (a) of Rule 144"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"Restricted Stock Vesting Under a Registered Plan"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
registered plan financial
"Restricted Stock Vesting Under a Registered Plan"
A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ATRC shares are proposed for sale, and what is their listed value?

The proposed sale covers 2,452 AtriCure common shares, with an aggregate market value of $143,397.13.

What broker and sale date are listed for the proposed ATRC sale?

Morgan Stanley Smith Barney LLC is listed as broker, and November 6, 2026 is the approximate sale date. The shares are described as acquired on May 20, 2021 through restricted stock vesting under a registered plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading